[ABCL] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
20-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -192.35%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 38,025 485,424 375,203 233,155 11,612 8,831 33.88%
PBT -174,029 239,099 219,149 157,833 -2,211 309 -
Tax -27,631 80,580 65,685 38,915 209 1,274 -
NP -146,398 158,519 153,464 118,918 -2,420 309 -
Tax Rate - -33.70% -29.97% -24.66% - -412.45% -
Total Cost 184,423 326,905 221,739 114,237 14,031 8,522 84.88%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -385.00 32.66 40.90 51.00 -20.84 3.50 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.51 0.56 0.56 0.44 -0.02 0.00 -
EPS Diluted -0.51 0.50 0.48 0.44 -0.02 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.